Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$35.55 - $43.57 $50,623 - $62,043
1,424 Added 0.39%
364,132 $15.8 Million
Q3 2023

Oct 25, 2023

SELL
$39.13 - $47.24 $3.45 Million - $4.17 Million
-88,207 Reduced 19.56%
362,708 $14.7 Million
Q2 2023

Aug 03, 2023

BUY
$43.93 - $46.76 $3.84 Million - $4.09 Million
87,490 Added 24.07%
450,915 $20.3 Million
Q1 2023

Apr 24, 2023

BUY
$45.29 - $50.76 $16.5 Million - $18.4 Million
363,425 New
363,425 $16.7 Million
Q3 2022

Oct 07, 2022

SELL
$40.9 - $50.42 $184,254 - $227,142
-4,505 Reduced 1.05%
426,553 $18 Million
Q2 2022

Aug 10, 2022

BUY
$42.98 - $49.77 $2.48 Million - $2.87 Million
57,597 Added 15.42%
431,058 $20.3 Million
Q1 2022

May 13, 2022

BUY
$42.23 - $54.3 $698,315 - $897,904
16,536 Added 4.63%
373,461 $18.3 Million
Q4 2021

Feb 14, 2022

BUY
$50.62 - $56.47 $708,680 - $790,580
14,000 Added 4.08%
356,925 $19.8 Million
Q3 2021

Nov 08, 2021

BUY
$46.55 - $56.83 $1.41 Million - $1.72 Million
30,290 Added 9.69%
342,925 $17.7 Million
Q2 2021

Aug 11, 2021

SELL
$46.28 - $52.75 $822,673 - $937,684
-17,776 Reduced 5.38%
312,635 $15.1 Million
Q1 2021

May 14, 2021

BUY
$46.25 - $56.02 $3.68 Million - $4.45 Million
79,472 Added 31.67%
330,411 $16.1 Million
Q4 2020

Feb 10, 2021

BUY
$46.09 - $54.74 $10.5 Million - $12.4 Million
227,006 Added 948.51%
250,939 $13.3 Million
Q3 2020

Nov 13, 2020

BUY
$42.51 - $52.42 $1.02 Million - $1.25 Million
23,933 New
23,933 $1.25 Million
Q4 2019

Feb 13, 2020

SELL
$25.41 - $43.1 $3.27 Million - $5.55 Million
-128,720 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$32.73 - $40.81 $4.86 Million - $6.06 Million
-148,562 Reduced 53.58%
128,720 $4.22 Million
Q2 2019

Aug 14, 2019

BUY
$35.73 - $41.39 $9.91 Million - $11.5 Million
277,282 New
277,282 $11.2 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.92B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.